Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 2020-June 2022

Rebecca A. Falender,Paul G. Mitchell,Judith A. Guzman-Cottrill,Paul R. Cieslak,Melissa Sutton

EMERGING INFECTIOUS DISEASES（2023）

引用 0|浏览8

暂无评分

摘要

We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence in-creased linearly during November 2020-December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%-46.5%). We observed no increase in the se-roprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cu-mulative incidence.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要